These articles are now archived and will no longer be updated.
Swansea University’s Professor Steve Conlan will be the keynote speaker at the world’s first virtual summit on cancer and immunology research.
He will be presenting his work to a global online audience of more than a million at next week’s SelectScience event.
As the spread of COVID-19 forces the postponement of key events in the science calendar, the Virtual Summit will offer a crucial forum for scientists and manufacturers to continue to connect.
Professor Conlan, head of the Reproductive Biology and Gynaecological Oncology research group at the University’s Medical School and Senior Affiliate Member at Houston Methodist Research Institute, said it was very important for science communication to carry on during the pandemic.
He said: “Great scientific advances come through collaboration and joint effort. Participating in the summit allows us to share our most recent advances in cancer immunotherapy.
“Interestingly this event will be attended by more people than a physical meeting would, so it expands the opportunity to meet new researchers and businesses, which will only serve to grow global collaboration.”
Hosted by science publisher SelectScience, scientists and scientific manufacturers will be joining the online event from across the world to explore headline topics including immunology and COVID-19, CAR T-cell therapy, immunotherapy, genomic research and CRISPR technology, cancer diagnostics, liquid biopsies, cancer imaging, drug delivery mechanisms, the microbiome and more.
The summit will feature presentations by top scientists and technology innovators, workshops, video interviews, virtual resource hubs, video interviews, the latest product and application news, as well as live-chat opportunities.
Register for free today and reserve your place. The summit will be open daily from Monday, May 11 to Wednesday, May 13 and delegates can drop in and out as desired.
Professor Conlan’s 30-minute talk will be at 1pm on Monday and will be followed by a live Q&A session